Dr. Tandy Tipps

Dr. Tandy Tipps, MEd, MPA, PhD, is the former Department Administrator for Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center, home to the world’s largest Phase I oncology program. She has held executive roles across the global CRO and biopharma landscape and brings extensive experience spanning first-in-human through Phase III oncology trials. She has also built strong relationships with leading academic institutions, integrated delivery networks, and community-based research centers around the world.

Beyond her professional accomplishments, Dr. Tipps brings a distinctive personal perspective shaped by deep Texas roots and a lasting connection to New York City. A fifth-generation Texan, she also considers herself a New Yorker after spending many years living in Manhattan. She often jokes that people would never know she is not from New York until she speaks and they hear her accent. Outside of work, she is an avid cyclist, a passionate supporter of animal rescue, and an enthusiastic traveler. She enjoys spending time outdoors, working in the yard, reading nonfiction, attending rock concerts, and listening to heavy metal. She loves the water, especially when it involves a jet ski, and values kindness, strong relationships, honesty, and being direct and upfront with a NO BULL attitude.

WINNIEDEL ONCOLOGY was founded as a loving testament to Dr. Tipps’ father and mother-in-law, who both passed away from cancer within six months of one another. Through her leadership role in the world’s largest Phase I oncology program at MD Anderson, and through her work with cancer centers, principal investigators, and key opinion leaders around the world, she saw that even the most promising cancer research could lose momentum because of barriers to early phase trial launch in oncology and precision medicine.

That experience shaped the mission of WINNIEDEL ONCOLOGY: to help bring new, novel, and life-saving therapeutics to patients sooner. Through its optimized study start-up model, Global Oncology Site Universe, and proven, agile development processes, WINNIEDEL ONCOLOGY accelerates trial execution while helping biotech companies save time and resources.